Amryt Pharma Holdings Ltd
LSE:AMYT
Balance Sheet
Balance Sheet Decomposition
Amryt Pharma Holdings Ltd
Current Assets | 276.8m |
Cash & Short-Term Investments | 123.2m |
Receivables | 52.8m |
Other Current Assets | 100.8m |
Non-Current Assets | 578.7m |
PP&E | 8.4m |
Intangibles | 488.7m |
Other Non-Current Assets | 81.5m |
Current Liabilities | 153.8m |
Other Current Liabilities | 153.8m |
Non-Current Liabilities | 395.6m |
Long-Term Debt | 200.6m |
Other Non-Current Liabilities | 195m |
Balance Sheet
Amryt Pharma Holdings Ltd
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
15
|
10
|
24
|
1
|
67
|
119
|
|
Cash |
0
|
0
|
24
|
1
|
0
|
0
|
|
Cash Equivalents |
15
|
10
|
0
|
0
|
67
|
119
|
|
Total Receivables |
0
|
0
|
4
|
6
|
36
|
43
|
|
Accounts Receivables |
0
|
0
|
4
|
6
|
36
|
43
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
1
|
2
|
58
|
41
|
|
Other Current Assets |
0
|
2
|
3
|
10
|
0
|
0
|
|
Total Current Assets |
0
|
0
|
32
|
19
|
161
|
203
|
|
PP&E Net |
0
|
0
|
1
|
1
|
3
|
8
|
|
PP&E Gross |
0
|
0
|
1
|
1
|
0
|
0
|
|
Accumulated Depreciation |
0
|
0
|
0
|
1
|
0
|
0
|
|
Intangible Assets |
0
|
0
|
64
|
60
|
342
|
305
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
2
|
|
Other Assets |
0
|
0
|
0
|
0
|
19
|
19
|
|
Total Assets |
0
N/A
|
0
N/A
|
97
N/A
|
81
-17%
|
527
+552%
|
537
+2%
|
|
Liabilities | |||||||
Accounts Payable |
0
|
2
|
6
|
5
|
0
|
0
|
|
Accrued Liabilities |
0
|
2
|
6
|
7
|
0
|
0
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
24
|
11
|
|
Total Current Liabilities |
0
|
0
|
12
|
12
|
102
|
101
|
|
Long-Term Debt |
0
|
0
|
13
|
19
|
178
|
188
|
|
Deferred Income Tax |
0
|
0
|
7
|
6
|
7
|
7
|
|
Other Liabilities |
0
|
0
|
39
|
47
|
107
|
174
|
|
Total Liabilities |
0
N/A
|
0
N/A
|
71
N/A
|
85
+20%
|
395
+368%
|
470
+19%
|
|
Equity | |||||||
Common Stock |
0
|
0
|
26
|
25
|
12
|
14
|
|
Retained Earnings |
0
|
0
|
69
|
97
|
117
|
1
|
|
Additional Paid In Capital |
0
|
0
|
69
|
68
|
2
|
51
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
0
N/A
|
0
N/A
|
27
N/A
|
4
N/A
|
132
N/A
|
66
-50%
|
|
Total Liabilities & Equity |
0
N/A
|
0
N/A
|
97
N/A
|
81
-17%
|
527
+552%
|
537
+2%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
0
|
0
|
46
|
46
|
154
|
179
|